Shagun Singh
Stock Analyst at RBC Capital
(3.21)
# 994
Out of 4,840 analysts
204
Total ratings
47.43%
Success rate
0.12%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Outperform | $105 → $101 | $80.68 | +25.19% | 21 | May 22, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $14 → $21 | $17.95 | +16.99% | 11 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $125 → $112 | $92.64 | +20.90% | 14 | May 6, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $150 → $145 | $120.78 | +20.05% | 20 | May 2, 2025 | |
| ZYXI Zynex | Maintains: Sector Perform | $5 → $4 | $2.40 | +66.67% | 7 | Apr 30, 2025 | |
| PEN Penumbra | Maintains: Outperform | $315 → $330 | $268.54 | +22.89% | 12 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $116 → $120 | $104.50 | +14.83% | 15 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $630 → $605 | $539.54 | +12.13% | 14 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $140 → $145 | $131.30 | +10.43% | 13 | Apr 17, 2025 | |
| JNJ Johnson & Johnson | Reiterates: Outperform | $181 | $152.94 | +18.35% | 20 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $215 | $143.21 | +50.13% | 5 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $340 | $321.50 | +5.75% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $55 | $20.72 | +165.44% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $74.99 | +13.35% | 21 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $376.62 | +15.50% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $58.96 | +56.04% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $84.51 | +36.08% | 4 | Oct 25, 2024 |
Medtronic
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $80.68
Upside: +25.19%
Outset Medical
May 21, 2025
Maintains: Sector Perform
Price Target: $14 → $21
Current: $17.95
Upside: +16.99%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $125 → $112
Current: $92.64
Upside: +20.90%
Teleflex
May 2, 2025
Maintains: Sector Perform
Price Target: $150 → $145
Current: $120.78
Upside: +20.05%
Zynex
Apr 30, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.40
Upside: +66.67%
Penumbra
Apr 24, 2025
Maintains: Outperform
Price Target: $315 → $330
Current: $268.54
Upside: +22.89%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $104.50
Upside: +14.83%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $630 → $605
Current: $539.54
Upside: +12.13%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $140 → $145
Current: $131.30
Upside: +10.43%
Johnson & Johnson
Apr 16, 2025
Reiterates: Outperform
Price Target: $181
Current: $152.94
Upside: +18.35%
Apr 15, 2025
Maintains: Outperform
Price Target: $260 → $215
Current: $143.21
Upside: +50.13%
Mar 6, 2025
Initiates: Outperform
Price Target: $340
Current: $321.50
Upside: +5.75%
Feb 27, 2025
Maintains: Outperform
Price Target: $65 → $55
Current: $20.72
Upside: +165.44%
Feb 12, 2025
Reiterates: Outperform
Price Target: $85
Current: $74.99
Upside: +13.35%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $376.62
Upside: +15.50%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $58.96
Upside: +56.04%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $84.51
Upside: +36.08%